Found 0 matching trials
Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls
PHASE3This study has been designed to evaluate the immunogenicity and safety of G...
Location
GSK Investigational Site
Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers
PHASE4The primary objectives of this study are to determine the acceptance and po...
ESCUDDO Long Term Follow Up
N/AThis study evaluates the long term protection provided by either one or two...
Status
Enrolling By Invitation
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Immunogenicity of Fractional Dose of the HPV Vaccines
PHASE4This randomized phase IV trial compares intramuscular and intradermal fract...
Status
Active Not Recruiting
Location
University of Washington Virology Research Clinic
Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls
PHASE3This randomized controlled trial will evaluate a bivalent HPV vaccine, Ceco...
Location
International Centre for Diarrhoeal Disease Research
Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study
PHASE4This phase IV trial investigates whether one dose of a human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
PHASE2A total of 480 Chinese women aged 18-26 years old were enrolle,experimental...
Location
Liucheng Center for Disease Control and Prevention
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
PHASE2Patients who undergo allogeneic stem cell transplantation lose previously a...
Location
Skåne's University Hospital
Provider Recommendation and HPV Vaccination
NAIn the United State, there are millions of US teens who are not vaccinated ...
Location
Kaiser Permanente Southern California
Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer
PHASE1The purpose of the study is to assess the safety, tolerability and the HPV-...